This study shows that there is a significant relationship between the metabolic pathology Polycystic Ovary Syndrome (PCOS) and the level of severity of COVID-19 (NG C-19). The sample consisted of 600 women of different age groups ("adolescent", "young adult", "middle adult" and older adult"). [...] The statistical analysis related to PCOS and NG C-19 had the chi-square tests with a p < 0.05. Of the 600 women in the sample present a relationship between polycystic ovarian disease on ultrasound, with the level of severity COVID-19 and the diagnosis of COVID-19 by PCR: asymptomatic correspond to 8.30%, mild symptomatology to 53.30%, medium symptomatology to 55.60% and severe symptomatology to 66.70% and correspond to 22.50% of the total sample (CT 1); with the diagnosis of COVID-19 by Antigen-Antibody: asymptomatic patients accounted for 7.30%, those with mild symptomatology 63.30%, those with medium symptomatology 88.90% and those with severe symptomatology 33.30% and accounted for 25.40% of the total sample (CT 2)...